DBV Technologies(DBVT)

0.8000 0.0074 0.9336%

今开：0.8396	昨收：0.7926
最高：0.84	最低：0.8
涨停价：0.0	跌停价：0.0
总市值：7.693738E7

DBV Technologies的热门讨论

当期报告

DBV Technologies(DBVT)05-08 04:45

$DBV Technologies(DBVT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-133209 Act: 34 Size: 334 KB 网页链接查看全文

其他

DBV Technologies(DBVT)04-26 20:25

$DBV Technologies(DBVT)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-115882 Act: 34 Size: 1 MB 网页链接查看全文

股东委托书协议

DBV Technologies(DBVT)04-26 20:15

$DBV Technologies(DBVT)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-115870 Act: 34 Size: 2 MB 网页链接查看全文

季度财报

DBV Technologies(DBVT)05-08 04:55

$DBV Technologies(DBVT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-24-133228 Act: 34 Size: 5 MB 网页链接查看全文

持股变动声明

DBV Technologies(DBVT)05-30 04:25

$DBV Technologies(DBVT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-014759 Size: 6 KB 网页链接查看全文

当期报告

DBV Technologies(DBVT)05-18 04:45

$DBV Technologies(DBVT)$ 8-K Current report, items 3.03, 7.01, and 9.01 Accession Number: 0001193125-24-141809 Act: 34 Size: 235 KB 网页链接查看全文

当期报告

DBV Technologies(DBVT)05-17 04:15

$DBV Technologies(DBVT)$ 8-K Current report, items 5.03 and 5.07 Accession Number: 0001193125-24-140531 Act: 34 Size: 400 KB 网页链接查看全文

当期报告

DBV Technologies(DBVT)06-01 04:15

$DBV Technologies(DBVT)$ 8-K Current report, items 3.03, 7.01, and 9.01 Accession Number: 0001193125-24-151728 Act: 34 Size: 245 KB 网页链接查看全文

其他

DBV Technologies(DBVT)05-18 05:25

$DBV Technologies(DBVT)$ F-6 POS Post-effective amendments for immediately effective filing Accession Number: 0001193805-24-000685 Act: 33 Size: 269 KB 网页链接查看全文

员工持股计划

DBV Technologies(DBVT)07-03 04:15

$DBV Technologies(DBVT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-174315 Act: 33 Size: 287 KB 网页链接查看全文

DBV Technologies的最新讨论

madliu13142020-09-01 21:59

$DBV Technologies(DBVT)$ aimt给收购了，市场认为dbvt已经玩完，不过这个公司帐上还有2亿美金，过敏的贴片过了三期给fda拒了，fda要求它要补充数据。现阶段股价和账面价值一致，也就是他家那些pipeline 的价值是零。查看全文

网络异常请稍后再试2020-08-04 20:13

$DBV Technologies(DBVT)$ $Aimmune治疗(AIMT)$
汝之砒霜,彼之蜜糖。虽然后者股价也跌成屎了
The rejection means Aimmune will have a clear path to take the peanut allergy market, but the company is facing its own issues. They had planned extensive training sessions with al...查看全文

chuminhua2020-06-27 21:31

6/26，今年1月，Aimmune的花生过敏药物获得批准，但是他们的竞争对手DBV Technologies$DBV Technologies(DBVT)$ 尚未得到FDA的消息。DBV计划裁减大量员工，作为全球全面重组计划的一部分。查看全文

清清爽爽普通人2020-03-18 20:50

$DBV Technologies(DBVT)$ 盘前大涨47% [为什么] 查看全文